Safety of Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial Fibrillation

• Автори: M. A. Gabitova (Автор), P. M. Krupenin (Автор), A. A. Sokolova (Автор), D. A. Napalkov (Автор), V. V. Fomin (Автор)
• Формат: Книга
• Опубліковано: Столичная издательская компания, 2020-01-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

Aim. To study the safety of non-vitamin K oral anticoagulants (NOAC) in patients with atrial fibrillation (AF) over 75 years old.Material and methods. The observation study included patients ≥75 years of age with confirmed AF, receiving dabigatran in a reduced dosage, apixaban or rivaroxaban in full...